Method for conducting a clinical study

• US 20040122714A1
• Filed: 12/23/2002
• Published: 06/24/2004
• Est. Priority Date: 12/23/2002
• Status: Abandoned Application

• Current Assignee: Siemens AG
• Original Assignee: Siemens AG
• Inventors: Kuth, Rainer, Zindel, Christoph
• Application Number:
  US10/327,787
• Publication Number:
  US 20040122714A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 30/20 for handling medical images, e.g. DICOM, HL7 or PACS

Abstract

In a method for conducting a clinical study, such as a clinical trial for governmental approval of a medical product, a medical facility is operated in a conventional manner over time in a number of interactions respectively with a number of patients and, for each interaction, data are produced and stored. For conducting a clinical study for a medical product that departs from the conventional interaction, an entity conducting the study identifies a need for specific data relevant to the clinical study. The stored data are made available to the entity, and the entity, or a representative of the entity, compares the stored data to the need and extracts data from the stored data to fulfill the need.

Claims

1. A method for conducting a clinical study comprising the steps of:

(a) operating a medical facility over time in a plurality of conventional interactions respectively with a plurality of patients and, for each of said interactions, producing data;

(b) storing said data as stored data;

.

(c) in a clinical study conducted by an evaluation entity for a medical product that departs from said conventional interaction, identifying a need for specific data relevant to said clinical study;

(d) making said stored data available to said entity; and

(e) said entity comparing said stored data to said need and extracting data from said stored data to fulfill said need.

2. A method as claimed in claim 1 wherein step (a) includes producing data including data representing an identity of each patient, and wherein step (b) comprises encrypting at least said data representing the identity of each patient.

3. A method as claimed in claim 1 wherein step (d) comprises making said stored data available to said entity directly from said medical facility.

4. A method as claimed in claim 1 wherein step (d) comprises communicating said stored data from said medical facility to a databank operator, and making said stored data available to said entity via said databank operator.

5. A method as claimed in claim 1 wherein step (b) comprises for each patient, providing a storage medium in which data produced by interaction of that patient with said medical facility are stored, and wherein step (d) comprises making said stored data available to said entity from said storage medium directly from each patient.

6. A method as claimed in claim 1 wherein said medical facility is a clinic which operates an imaging device, sold by an imaging device manufacturer, and wherein said interactions comprise respective examinations of patients with said imaging device.

7. A method as claimed in claim 6 comprising the additional step of establishing a contractual relationship between said imaging device manufacturer and said entity, and wherein step (d) comprises making said stored data available to said entity dependent on said contractual relationship.

8. A method as claimed in claim 6 comprising providing consideration from said imaging device manufacturer to said clinic upon a sale of said imaging device from said imaging device manufacturer to said clinic in return for said clinic making said stored data available to said entity in step (d).

9. A method as claimed in claim 8 wherein said entity is a pharmaceutical manufacturer and wherein said examination includes administration of a contrast agent and wherein step (c) comprises identifying a need for specific data relating to diagnosis of patients using said contrast agent.

10. A method as claimed in claim 1 wherein step (a) comprises producing said data for each of said interactions with said respective patient selected from the group consisting of, for each patient, a patient identifier, date of birth, sex, body weight, reason for the interaction, and findings resulting from the interaction.

11. A method as claimed in claim 1 wherein step (a) comprises producing said data for each of said interactions with said respective patient selected from the group consisting of, for each patient, a patient identifier, date of birth, sex, body weight, reason for the interaction, findings resulting from the interaction, genetic data, cause of death of close relatives, blood type, other illnesses, medical images, and other measured data.